Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coupang
CPNG
|
+$1.83B |
| 2 |
Roblox
RBLX
|
+$1.63B |
| 3 |
BILL Holdings
BILL
|
+$1.46B |
| 4 |
Airbnb
ABNB
|
+$774M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$620M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$2.32B |
| 2 |
Spotify
SPOT
|
+$1.39B |
| 3 |
Okta
OKTA
|
+$1.24B |
| 4 |
Alibaba
BABA
|
+$1.16B |
| 5 |
Amazon
AMZN
|
+$1.05B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.4% |
| 2 | Healthcare | 9.82% |
| 3 | Financials | 9.22% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Communication Services | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3926
Rigel Pharmaceuticals
RIGL
$750M
| $3.86M | ﹤0.01% |
106,304
-34,048
| -24% | -$1.34M |
|
3927
Nuveen Select Tax-Free Income Portfolio
NXP
$900M
| $3.86M | ﹤0.01% |
221,868
+3,085
| +1% | +$53.9K |
|
3928
QuinStreet
QNST
$1.21B
| $3.85M | ﹤0.01% |
219,523
-281,516
| -56% | -$5.06M |
|
3929
Cars.com
CARS
$660M
| $3.85M | ﹤0.01% |
304,520
-58,673
| -16% | -$742K |
|
3930
Invesco S&P SmallCap Consumer Discretionary ETF
PSCD
$24.4M
| $3.84M | ﹤0.01% |
35,642
-20,384
| -36% | -$2.29M |
|
|
TRST
3931
Trustco Bank Corp NY
TRST
$938M
| $3.84M | ﹤0.01% |
120,041
-2,574
| -2% | -$84.1K |
|
3932
CVR Energy
CVI
$3.13B
| $3.83M | ﹤0.01% |
230,064
-64,896
| -22% | -$915K |
|
|
MAG
3933
DELISTED
MAG Silver
MAG
| $3.83M | ﹤0.01% |
236,458
+52,976
| +29% | +$991K |
|
|
STON
3934
DELISTED
StoneMor Inc.
STON
| $3.83M | ﹤0.01% |
1,548,985
+3,946
| +0.3% | +$10.1K |
|
3935
Scholastic
SCHL
$792M
| $3.82M | ﹤0.01% |
107,194
-9,426
| -8% | -$322K |
|
3936
First Merchants
FRME
$2.67B
| $3.81M | ﹤0.01% |
90,976
-57
| -0.1% | -$2.32K |
|
3937
Bionano Genomics
BNGO
$13.3M
| $3.81M | ﹤0.01% |
1,153
-1,627
| -59% | -$5.69M |
|
|
AVTA
3938
DELISTED
Avantax, Inc. Common Stock
AVTA
| $3.81M | ﹤0.01% |
244,110
-22,718
| -9% | -$367K |
|
3939
Tucows
TCX
$175M
| $3.81M | ﹤0.01% |
48,194
+13,184
| +38% | +$1.02M |
|
|
ASXC
3940
DELISTED
Asensus Surgical, Inc.
ASXC
| $3.8M | ﹤0.01% |
2,054,254
+1,098,753
| +115% | +$2.47M |
|
3941
Invesco Pharmaceuticals ETF
PJP
$479M
| $3.79M | ﹤0.01% |
48,988
+10,573
| +28% | +$853K |
|
3942
Liquidity Services
LQDT
$1.32B
| $3.79M | ﹤0.01% |
175,100
-80,428
| -31% | -$1.83M |
|
|
PDS
3943
Precision Drilling
PDS
$974M
| $3.79M | ﹤0.01% |
93,662
-39,140
| -29% | -$1.35M |
|
3944
TriCo Bancshares
TCBK
$1.83B
| $3.78M | ﹤0.01% |
87,056
+6,620
| +8% | +$268K |
|
|
VIVO
3945
DELISTED
Meridian Bioscience Inc
VIVO
| $3.77M | ﹤0.01% |
196,201
+18,351
| +10% | +$366K |
|
3946
Alpha and Omega Semiconductor
AOSL
$1.08B
| $3.77M | ﹤0.01% |
120,212
-106,095
| -47% | -$2.94M |
|
|
VRAY
3947
DELISTED
ViewRay, Inc.
VRAY
| $3.77M | ﹤0.01% |
523,019
-147,945
| -22% | -$934K |
|
|
GAM
3948
General American Investors Company
GAM
$1.61B
| $3.77M | ﹤0.01% |
87,487
-3,945
| -4% | -$173K |
|
3949
iShares MSCI Poland ETF
EPOL
$756M
| $3.77M | ﹤0.01% |
171,790
-9,435
| -5% | -$209K |
|
3950
Goldman Sachs ActiveBeta Europe Equity ETF
GSEU
$126M
| $3.77M | ﹤0.01% |
106,152
+10,722
| +11% | +$401K |
|
Similar funds
Morgan Stanley's Q3 2021 Portfolio in Review
As of Q3 2021, Morgan Stanley held 8,301 positions worth $742B, down 2.1% from $758B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Morgan Stanley's Q3 2021 filing shows 450 new, 3,451 increased, 3,331 reduced and 228 closed positions. Its largest new stake was Ginkgo Bioworks: 281,861 shares worth $131M. The largest sale was Alphabet (Google) Class C, an estimated $2.32B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2021 buy was Ginkgo Bioworks: 281,861 shares worth $131M.
- Morgan Stanley added most to Coupang in Q3 2021, an estimated $1.83B increase.
- Morgan Stanley's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $2.32B.
- Morgan Stanley fully exited Proofpoint, Inc. in Q3 2021, selling an estimated $441M.
- Morgan Stanley's ten largest holdings make up 15% of its $742B portfolio in Q3 2021.
- Morgan Stanley opened 450 new positions and closed 228 in Q3 2021.
- Morgan Stanley's portfolio value fell 2.1% quarter-over-quarter to $742B.
Based on Morgan Stanley's 13F filing for Q3 2021, filed 15 Nov 2021.